Evidence map›Paper›PMID 30662360›Full record

ArticleInternational journal of biological sciences2019

Establishing a prediction model for prostate cancer bone metastasis.

Song Chen, Lu Wang, Kaiyu Qian, Wei Jiang, Haiqing Deng, Qiang Zhou, Gang Wang, Xuefeng Liu, Chin-Lee Wu, Yu Xiao and 1 more

Abstract read
In one paragraph

Article in International journal of biological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Distinguishable Colorimetric Biosensor for Diagnosis of Prostate Cancer Bone Metastases.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Song ChenDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Lu WangDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Kaiyu QianDepartment of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wei JiangHuman Genetics Resource Preservation Center of Wuhan University, Wuhan, China.
Haiqing DengDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, China.
Qiang ZhouDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Gang WangDepartment of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xuefeng LiuDepartment of Pathology, Lombardi Comprehensive Cancer Center, Georgetown University Medical School, Washington DC, USA.
Chin-Lee WuDepartment of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Yu XiaoDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xinghuan WangDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We collected clinical data from 308 prostate cancer (PCa) patients to investigate the clinical characteristics and independent risk factors of bone metastasis (BM) and to establish a prediction model for BM of PCa and determine the necessity of bone scans. Univariate and multivariate analyses were performed based on age, biopsy Gleason score (BGS), clinical tumor stage (cTx), total prostate specific antigen (tPSA), free prostate specific antigen (fPSA), fPSA/tPSA, prostate volume, alkaline phosphatase (ALP), serum calcium and serum phosphorus. Moreover, 80 of the 308 PCa patients had a PI-RADS v2 score and were analysed retrospectively. The univariate analysis showed that the BGS, cTx, tPSA, fPSA, prostate volume and ALP were significant. The multivariate logistic regression analysis showed significant differences among the BGS, cTx, tPSA and ALP. Four cases should be highly suspected with BM: (i) cTl-cT2, BGS ≤7, ALP >120 U/L and tPSA >90.64 ng/ml; (ii) cTl-cT2, BGS ≥8, and ALP >120 U/L; (iii) cT3-cT4, BGS ≤7, and ALP >120 U/L; and (iv) cT3-cT4 and BGS ≥8. After the PI-RADS v2 score was included in the model, the AUC of the prediction model rose from 0.884 (95% CI: 0.813-0.996) to 0.934 (95% CI: 0.883-0.986). This model may help determine the necessity of bone scans to diagnose BM for PCa patients.

Indexed as

Models, TheoreticalAlkaline PhosphataseBone NeoplasmsCalciumHumansMaleMultivariate AnalysisPhosphorusProstate-Specific AntigenProstatic NeoplasmsRetrospective StudiesRisk FactorsAlkaline PhosphataseCalciumPhosphorusProstate-Specific AntigenALPBGSbone metastasiscTxPI-RADS v2Prediction analysis modelprostate cancertPSA

Identifiers

PMID30662360
PMCPMC6329914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.